The Patent Finder

Aventis Pasteur Limited/Aventis Pasteur Limiteee

Also on record
Records under this name other than patents Aventis Pasteur Limited/Aventis Pasteur Limiteee holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.

Back to Aventis Pasteur Limited/Aventis Pasteur Limiteee

Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
PatentTitleStatus Expires Confidence
US 8,293,249Nucleic Acid and Amino Acid Sequences Relating to Streptococcus Pneumoniae for Diagnostics and Therapeutics
Formerly held
Term ended
Term ended Apr 13, 2019 · Medium confidence
Term endedTerm ended Apr 13, 2019Medium confidence
US 8,298,788Nucleic Acid and Amino Acid Sequences Relating to Streptococcus Pneumoniae for Diagnostics and Therapeutics
Formerly held
Term ended
Term ended Apr 10, 2019 · Medium confidence
Term endedTerm ended Apr 10, 2019Medium confidence
US 6,368,589Use of autologous promoters to express gene products in Bordetella
Term ended
Ended no later than Apr 9, 2019 · USPTO record
Term endedEnded no later than Apr 9, 2019USPTO record
US 6,291,227Nucleic acids containing modified human immunodeficiency virus genomes devoid of long terminal repeats encoding non-infectious, replication-deficient, immunogenic retrovirus-like particles
Term ended
Term ended Sep 18, 2018 · USPTO record
Term endedTerm ended Sep 18, 2018USPTO record
US 7,122,368Nucleic Acid and Amino Acid Sequences Relating to Streptococcus Pneumoniae for Diagnostics and Therapeutics
Formerly held
Term ended
Term ended Jun 30, 2018 · Medium confidence
Term endedTerm ended Jun 30, 2018Medium confidence
US 8,609,107Nucleic Acid and Amino Acid Sequences Relating to Streptococcus Pneumoniae for Diagnostics and Therapeutics
Formerly held
Term ended
Term ended Jun 30, 2018 · Medium confidence
Term endedTerm ended Jun 30, 2018Medium confidence
US 6,264,954Haemophilus outer membrane protein
Term ended
Term ended Oct 1, 2017 · USPTO record
Term endedTerm ended Oct 1, 2017USPTO record
US 6,872,814Chlamydia antigens and corresponding DNA fragments and uses thereof
Lapsed on the fee record
Ended Mar 29, 2017 · USPTO record
Lapsed on the fee recordEnded Mar 29, 2017USPTO record
US 7,442,523Nucleic Acid and Amino Acid Sequences Relating to Streptococcus Pneumoniae for Diagnostics and Therapeutics
Formerly held
Lapsed on the fee record
Ended Oct 28, 2016 · Medium confidence
Lapsed on the fee recordEnded Oct 28, 2016Medium confidence
US 8,293,884Nucleic Acid and Amino Acid Sequences Relating to Streptococcus Pneumoniae for Diagnostics and Therapeutics
Formerly held
Lapsed on the fee record
Ended Oct 23, 2016 · Medium confidence
Lapsed on the fee recordEnded Oct 23, 2016Medium confidence
10 of 43 patents shown.
Pro members see all 43.
Pro members: see all 43 patents
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 19, 2026 · includes USPTO assignment data published Nov 18, 2026, status data published Nov 19, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited